Biotech Group Acquisition Corporation (BGAC)

Biotech Group Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap130.10M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out13.01M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BGAC

Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (...

IndustryBlank Check / SPAC
Founded2022
CEOYiru (Melody) Shi
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolBGAC
Full Company Profile

News

Biotech Group Acquisition IPO Registration Document (S-1)

Biotech Group Acquisition has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC